Court Weighs Mifepristone Rules | Tulsa News

A federal appeals court is weighing whether Louisiana has the legal right to challenge FDA rules governing mifepristone, the drug used in most U.S. abortions. As states tighten or ban abortion access, opponents are pushing to restrict how this medication is prescribed and distributed — especially across state lines. The case pits Louisiana’s Attorney General against the FDA and drugmakers, with judges questioning whether the real issue is state “shield laws” or federal regulation. Meanwhile, hundreds of women in Louisiana may have accessed pills from out-of-state providers, and while the Supreme Court previously blocked changes to prescribing rules, other states are also challenging the FDA — which plans to update its review by October seventh. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/5a5a5a35f0d02498